| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/09/2007 | EP1781326A2 Induction of an immune response against streptococcus pneumoniae polysaccharides |
| 05/09/2007 | EP1781279A2 Preparation for the prevention and treatment of stress conditions as well as functional and organic disorders of the nervous system and metabolic disorders |
| 05/09/2007 | EP1781257A2 Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent |
| 05/09/2007 | EP1781256A1 Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
| 05/09/2007 | EP1781220A2 Biocompatible polymeric vesicles self assembled from triblock copolymers |
| 05/09/2007 | EP1545623B1 Conjugates of insulin-like growth factor binding protein-4 and poly (ethylene glycol) |
| 05/09/2007 | EP1487469A4 Co-beadlet of dha and rosemary and methods of use |
| 05/09/2007 | EP1435874A4 Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners |
| 05/09/2007 | EP1401503B1 Pharmaceutical compositions containing a solid dispersion of a poorly-soluble drug and a solubility-enhancing polymer |
| 05/09/2007 | EP1289474B1 Low emulsifier multiple emulsions |
| 05/09/2007 | EP1156829B1 Stable formulation containing fumagillin |
| 05/09/2007 | EP0711177B1 Improvements relating to the preparation of prodrugs |
| 05/09/2007 | EP0708660B1 Compounds useful for preparing prodrugs of protein tyrosine kinase inhibitors |
| 05/09/2007 | EP0692029B1 Genetically engineered glutaminase and its use in therapy |
| 05/09/2007 | CN1960766A Novel G-CSF conjugates |
| 05/09/2007 | CN1960765A Drug delivery system |
| 05/09/2007 | CN1960756A Cytotoxicity mediation of cells evidencing cell membrane surface expression of CD63 |
| 05/09/2007 | CN1960755A Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| 05/09/2007 | CN1960754A Cancer regulation antibody |
| 05/09/2007 | CN1960752A Medical uses of carrier conjugates of non-human TNF-peptides |
| 05/09/2007 | CN1960746A A biomolecule-containing formulation of increased stability |
| 05/09/2007 | CN1960736A Anti-infectious hydrogel compositions |
| 05/09/2007 | CN1960729A 伊立替康制剂 Irinotecan preparations |
| 05/09/2007 | CN1960718A Sprayable composition for the administration of vitamin D derivatives |
| 05/09/2007 | CN1960716A Oral preparations and process for production thereof |
| 05/09/2007 | CN1960707A Liposomal assembly for therapeutic and/or diagnostic use |
| 05/09/2007 | CN1960705A Therapeutic foam |
| 05/09/2007 | CN1958074A Injectable block copolymer hydrogel of temperature sensibilityú¿epsi ¿C caprolactone - glycolideú®- polyethyleneglycol |
| 05/09/2007 | CN1958073A External use medicament for onychomycosis in fingernails or toe nails |
| 05/09/2007 | CN1957955A Soft capsule of Chinese traditional medicine, preparation method, and quality control method |
| 05/09/2007 | CN1957940A Formula for dispelling pox |
| 05/09/2007 | CN1957935A Drop pills of seabuckthorn fruit flavone, and preparation method |
| 05/09/2007 | CN1957929A New type medication preparation of containing isosorbide dinitrate or isosorbide nitrate |
| 05/09/2007 | CN1957926A Controlled release microparticles of Nano medication of curcumin, and preparation method |
| 05/09/2007 | CN1957923A A kind of controlled release injection of carried fluorouracil and synergis |
| 05/09/2007 | CN1957922A Controlled release agent of containing fluorouracil and synergis |
| 05/09/2007 | CN1957921A Controlled release injection of carried fluorouracil and synergis |
| 05/09/2007 | CN1957920A Anti cancer controlled release agent of carried fluorouracil and synergist |
| 05/09/2007 | CN1957919A Controlled release agent of containing fluorouracil and synergist |
| 05/09/2007 | CN1957916A Anti cancer controlled release agent of carried interstitial hydrolytic agent and derivative of Epothilone |
| 05/09/2007 | CN1957915A Anti cancer controlled release agent of carried interstitial hydrolytic agent and medication of cell toxin |
| 05/09/2007 | CN1957914A Anti cancer controlled release agent of carried interstitial hydrolytic agent and medication of cell elements |
| 05/09/2007 | CN1957913A Composition of anti cancer medication prepared from carried platinum category compound and consubstantial hydrolytic agent |
| 05/09/2007 | CN1957912A Anti cancer controlled release formulation of containing interstitial hydrolytic agent |
| 05/09/2007 | CN1957911A Controlled release formulation for anti entity tumour |
| 05/09/2007 | CN1957910A Anti cancer controlled release formulation of containing consubstantial hydrolytic agent |
| 05/09/2007 | CN1314806C Miniaturized polypeptide of anti EB Virus tumour, application and preparation method |
| 05/09/2007 | CN1314704C Oligopeptide suppressor of matrix metalloprotease 2 |
| 05/09/2007 | CN1314702C Cholestrin derivative as nucleoside analog |
| 05/09/2007 | CN1314586C Calcium metasilicates and methods for making the same |
| 05/09/2007 | CN1314453C Stable stored composite emulsion carrier in even dimension for hydrophilicity medication and preparation method |
| 05/09/2007 | CN1314452C Ocular in-situ gel preparation with proper phase conversion temperature |
| 05/09/2007 | CN1314451C Orally administered liquid compositions comprising guaifenesin and a polyoxyalkylene block copolymer |
| 05/09/2007 | CN1314445C Pulmonary administration of chemically modified insulin |
| 05/09/2007 | CN1314436C Noontime tea volatile oil-beta cyclo dextrin inclusion compound and its preparation technology |
| 05/09/2007 | CN1314390C Pharmaceutical dosage form with multiple coatings |
| 05/08/2007 | US7214717 Polydisperse double emulsion, corresponding monodisperse double emulsion and method for preparing the monodisperse emulsion |
| 05/08/2007 | US7214710 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 05/08/2007 | US7214707 Dimeric compounds and their use as anti-viral agents |
| 05/08/2007 | US7214663 The prodrug of the invention is a modified form of a therapeutic agent and comprises a therapeutic agent, an oligopeptide of three amino acids, a stabilizing group and, optionally, a linker group. The prodrug is cleavable by a |
| 05/08/2007 | US7214662 Prevents the aggregation of LHRH antagonists in solutions; bioavailability |
| 05/08/2007 | US7214661 Methods of therapy with thrombin derived peptides |
| 05/08/2007 | US7214657 Method of transporting a chimeric hybrid molecule across the blood brain barrier |
| 05/08/2007 | US7214512 Genomic mammary Amyloid a sequence |
| 05/08/2007 | US7214393 Administering an anti-allergy composition of a wood-vinegar distilled solution, colorless and transparent |
| 05/08/2007 | US7214389 Wet granulation of a pharmaceutical using a halogenated hydrocarbon (especially 1,1,1,2-tetrafluoroethane) as a granulating fluid |
| 05/08/2007 | US7214388 Gels; immobilization of proteins; drug delivery |
| 05/08/2007 | US7214387 Antidiabetic agents |
| 05/08/2007 | US7214384 Lipid-conjugated polyamide compounds |
| 05/08/2007 | US7214381 Combination of a saturated or unsaturated fatty alcohol or fatty acid; a C1/C4 alkanol; a polyalcohol in particular propylenglycol; water; and optionally a monoalkylether of diethylene glycol as a permeation enhancer |
| 05/08/2007 | US7214366 Linking a sulfur compound directly to a terminal carbon of polyethyleneglycol, polyalkylene oxides or a polyvinyl alcohol; converting the sulfur to an active ethyl sulfone group having a reactive site located at the second carbon from the sulfone group; modifying biologically active molecules |
| 05/08/2007 | US7214365 Hydrophilic ingredient such as biotin, carnitine and derivatives thereof, creatine and derivatives thereof, folic acid, pyridoxine, niacinamide, polyphenols, ascorbic acid, Hamamelis, Aloe, or panthenol containing as a photostabilizer a di(C 6-24 branched or unbranched alkyl) 2,6-naphthalenedicarboxylate |
| 05/08/2007 | US7214223 Photoatherolytic catheter apparatus and method |
| 05/08/2007 | CA2427764C Transdermal drug delivery system with improved water absorbability and adhesion properties |
| 05/08/2007 | CA2328314C Long chain alcohols admixed in sterol compounds |
| 05/08/2007 | CA2267498C Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 05/08/2007 | CA2247526C Maltitol crystals having specific shapes, crystalline compositions containing them and processes for preparing them |
| 05/08/2007 | CA2235520C Bioadhesive tablets |
| 05/03/2007 | WO2007051071A2 Two-step method of functionalizing carbon allotropes and pegylated carbon allotropes made by such methods |
| 05/03/2007 | WO2007050651A1 Selective vpac2 receptor peptide agonists |
| 05/03/2007 | WO2007050574A1 Formulation comprising a drug of low water solubility and method of use thereof |
| 05/03/2007 | WO2007049868A1 Stabilized pharmaceutical oral preparation containing clopidogrel bisulfate |
| 05/03/2007 | WO2007049731A1 Novel cell membrane-permeable peptide |
| 05/03/2007 | WO2007049708A1 Ultrasonic cancer therapy accelerator and cytotoxic agent |
| 05/03/2007 | WO2007049626A1 Oral solid preparation containing cabergoline |
| 05/03/2007 | WO2007049587A1 Enteric-coated preparation |
| 05/03/2007 | WO2007049304A2 Stable coated pharmaceutical formulation of olanzapine and process for preparing the same |
| 05/03/2007 | WO2007049102A1 Method of preparing an aqueous pharmaceutical composition comprising hydroxypropyl methylcellulose and pharmaceutical c0mp0siti0ns obtainable |
| 05/03/2007 | WO2007049044A1 Siglec-9 binding agents |
| 05/03/2007 | WO2007048599A2 Drug-delivery systems |
| 05/03/2007 | WO2007048326A1 Nanometer targeted drug for magneto-thermotherapy of malignant tumors |
| 05/03/2007 | WO2007048233A1 Stabilized extended release pharmaceutical compositions comprising a beta-adrenoreceptor antagonist |
| 05/03/2007 | WO2007025988A3 Liquid formulations of pegylated growth hormone |
| 05/03/2007 | WO2007014848A3 Stabilization of body-care and household products against degradation by uv radiation using merocyanine derivatives |
| 05/03/2007 | WO2007012838A3 Drug delivery system |
| 05/03/2007 | WO2007012059A3 Method for preparing polymer maleimides |
| 05/03/2007 | WO2006138534A3 Stable warfarin sodium liquid formulation and method of making same |
| 05/03/2007 | WO2006119957A3 Method for opening hollow structures made from magnetic nanoparticles |
| 05/03/2007 | WO2005094896A3 Targeted serotonin reuptake inhibitors |
| 05/03/2007 | WO2005023331A3 Hydrogel nanocompsites for ophthalmic applications |